Works matching IS 14642662 AND DT 2000 AND VI 1

Results: 119

Management of protozoal diarrhoea in HIV disease.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 194, doi. 10.1046/j.1468-1293.2000.00028.x

By:

Miao, YM;
Gazzard, BG

Publication type:

Article

Octapeptide but not nonapeptide from HIV-1 p24<sup>gag</sup> protein upregulates cell surface HLA-C expression.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 200, doi. 10.1046/j.1468-1293.2000.00029.x

By:

Kozłowska, A;
Gorczyca, W;
Maćkiewicz, Z;
Wojciechowska, I;
Kuśnierczyk, P

Publication type:

Article

Proviral HIV-1 dynamics and evolution in patients receiving efficient long-term antiretroviral combination therapy.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 205, doi. 10.1046/j.1468-1293.2000.00030.x

By:

Birk, M;
Aleman, S;
Visco-Comandini, U;
Sönnerborg, A

Publication type:

Article

Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 years.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 212, doi. 10.1046/j.1468-1293.2000.00031.x

By:

Madge, S;
Mocroft, A;
Wilson, D;
Youle, M;
Lipman, MCI;
Phillips, A;
Tyrer, M;
Cozzi-Lepri, A;
Swaden, L;
Johnson, MA

Publication type:

Article

Detection of Mycoplasma fermentans in broncho-alveolar lavage fluid specimens from AIDS patients with lower respiratory tract infection.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 219, doi. 10.1046/j.1468-1293.2000.00032.x

By:

Ainsworth, Jg;
Clarke, J;
Lipman, M;
Mitchell, D;
Taylor-Robinson, D

Publication type:

Article

Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE.

Published in:: HIV Medicine, 2000, v. 1, n. 4, p. 224, doi. 10.1046/j.1468-1293.2000.00033.x
Publication type:: Article

Factors predictive of disease progression and death in AIDS-related Kaposi's sarcoma.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 232, doi. 10.1046/j.1468-1293.2000.00034.x

By:

Spano, J-P;
Salhi, Y;
Costagliola, D;
Rozenbaum, W;
Girard, P-M

Publication type:

Article

The shrinking of human rights: the controversial revision of the Helsinki Declaration.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 238, doi. 10.1046/j.1468-1293.2000.00035.x

By:

Botbol-Baum, M

Publication type:

Article

Economic impact of HIV protease inhibitor therapy in the global use of health-care resources.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 246, doi. 10.1046/j.1468-1293.2000.00036.x

By:

Velasco, M;
Gómez, A;
Fernández, C;
Pérez-Cecilia, E;
Téllez, MJ;
Roca, V;
Fernández-Cruz, A

Publication type:

Article

Is acute appendicitis another inflammatory condition associated with highly active antiretroviral therapy (HAART)?

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 252, doi. 10.1046/j.1468-1293.2000.00037.x

By:

Aldeen, T;
Horgan, M;
Macallan, D C.;
Thomas, V;
Hay, P

Publication type:

Article

Occupational HIV infection documented by sequence analysis of source and index virus strains.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 256, doi. 10.1046/j.1468-1293.2000.00038.x

By:

Salzberger, B;
Wiesel, W;
Schwingel, E;
Hauber, I

Publication type:

Article

Referees for Volume 1.

Published in:: HIV Medicine, 2000, v. 1, n. 4, p. 259
Publication type:: Article

Author Index.

Published in:: HIV Medicine, 2000, v. 1, n. 4, p. 261
Publication type:: Article

XIII World AIDS Conference.

Published in:

HIV Medicine, 2000, v. 1, n. 4, p. 191, doi. 10.1046/j.1468-1293.2000.00042.x

By:

Gazzard, B.

Publication type:

Article

Commentary on the summary of the French Guidelines for the treatment of HIV-infected adults with antiretroviral therapy.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 132, doi. 10.1046/j.1468-1293.2000.00017.x

By:

De Wit, S

Publication type:

Article

New French guidelines for antiretroviral treatment.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 133

By:

Delfraissy, J-F;
of, behalf;
of French researchers, a consensus panel composed;
advocates, community

Publication type:

Article

How generalizable are the results of large randomized controlled trials of antiretroviral therapy?

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 149, doi. 10.1046/j.1468-1293.2000.00019.x

By:

Moore, Daj;
Goodall, Rl;
Ives, Nj;
Hooker, M;
Gazzard, Bg;
Easterbrook, Pj

Publication type:

Article

A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug users.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 162, doi. 10.1046/j.1468-1293.2000.00020.x

By:

Staszewski, S;
Haberl, A;
Carlebach, A;
Rottmann, C;
Miller, V;
Gute, P

Publication type:

Article

A case of lipodystrophy after the initiation of zidovudine, lamivudine and efavirenz in an asymptomatic HIV-1-infected patient.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 164, doi. 10.1046/j.1468-1293.2000.00021.x

By:

Rickerts, V;
Bickel, M;
Tews, J;
Jacobi, V;
Staszewski, S

Publication type:

Article

Disseminated infection due to Encephalitozoon cuniculi in a patient with AIDS: case report and review.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 155, doi. 10.1046/j.1468-1293.2000.00022.x

By:

Fournier, S;
Liguory, O;
Sarfati, C;
David-Ouaknine, F;
Derouin, F;
Decazes, Jm;
Molina, Jm

Publication type:

Article

Management of HIV and pregnancy in England's North Thames Region 1999: a survey of practice in 21 hospitals.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 143, doi. 10.1046/j.1468-1293.2000.00023.x

By:

Brook, Mg;
Taylor, Gp;
Dale, A;
Lyall, Egh;
Tomlinson, D

Publication type:

Article

O1 Compartmentalization of resistance mutations in HIV-1 between the lung and peripheral blood.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-1.x

By:

White, N. C.;
Israel-Biet, D.;
Coker, R.;
Mitchell, D.;
Clarke, J. R.;
Weber, J. N.

Publication type:

Article

010 Quadruple HAART in primary infection: results from QUEST.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 168

By:

Lampe, F;
Phillips, An;
Kinloch, S;
Johnson, M;
Goh, L;
Hawkins, D;
Gazzard, B;
Fisher, M;
Freedman, A;
Group, Study

Publication type:

Article

011 The viral response to HAART over the first 16 weeks of therapy according to the pre-HAART and the 4–8-week viral load.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-21.x

By:

Lepri, A Cozzi;
Miller, V;
Phillips, An;
Rabenau, H;
Sabin, C;
Staszewski, S

Publication type:

Article

012 AIDS-related lymphoma in the era of HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-23.x

By:

Matthews, G;
Bower, M;
Mandalia, S;
Powles, T;
Nelson, M;
Gazzard, B

Publication type:

Article

013 Normalization of intestinal permeability following antiretroviral therapy in HIV+ patients with diarrhoea.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 169, doi. 10.1046/j.1468-1293.2000.00024-25.x

By:

Miao, Ym;
Bjarnason, I.;
Crane, R;
Hayes, P;
Gazzard, B

Publication type:

Article

014 Does TB treatment alter virological and immunological response to HAART?

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-27.x

By:

Dean, Gl;
Edwards, Sg;
Navaratne, L;
Matthews, G;
Fox, Ef;
Wood, Cg;
Fisher, M;
Churchill, Dr;
Taylor, Gp;
de Ruiter, A;
Taylor, C;
Pozniak, A

Publication type:

Article

015 Rapid onset lipodystrophy syndrome (LD) in three patients with prior severe nucleoside toxicity.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-29.x

By:

de Burgh Thomas, A;
Creighton, S;
Edwards, Sg;
Taylor, C

Publication type:

Article

016 Type III hyperlipidaemia, related to PI treatment, is not caused by homozygosity for apoE2.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 170, doi. 10.1046/j.1468-1293.2000.00024-31.x

By:

Jaleel, H;
Shahmanesh, M;
DeSilva, Y;
Ross, Jdc;
Caslake, M;
Cramb, R

Publication type:

Article

017 A prospective study of lipid metabolism in HIV-1-seropositive patients treated with HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-33.x

By:

Morlese, J;
Ware, L;
Kruger, M;
Pozniak, A;
Jackson, A;
Wooton, S;
Gazzard, B

Publication type:

Article

O18 A dichotomy in CD4 T-cell responses specific to HIV antigens.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-35.x

By:

Gotch, Fm;
Imami, N;
Gill, J;
Westby, M;
Wilson, Jdk

Publication type:

Article

O19 CD4+ T–cell responses in early HIV infection.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 171, doi. 10.1046/j.1468-1293.2000.00024-37.x

By:

Gloster, Se;
Harrop, R;
Newton, Pj;
Cornforth, Dm;
Balfe, P;
Williams, Ig;
Borrow, P

Publication type:

Article

O2 Comparison of viral drug resistance, adherence and PK indices in patients on successful and failing PI-based regimens.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-3.x

By:

Walsh, Jc;
Brown, S;
Gazzard, B

Publication type:

Article

020 Antibody responses to HIV Gag and Env following highly active antiretroviral therapy (HAART).

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-39.x

By:

Deayton, J;
Cope, Av;
Sabin, C;
Johnson, M;
Griffiths, Pd;
Emery, Vc

Publication type:

Article

021 Assessment of thymic activity by positron emission tomography in HIV patients on HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-41.x

By:

Worrell, S;
Hardy, G;
Hayes, P;
Aspinal, R;
Barnett, C;
Dutton, J;
Gotch, Fm;
Gazzard, B

Publication type:

Article

022 A heterosexual outbreak in Doncaster involving subtype B of HIV-1: molecular epidemiology as a supplement to contact tracing.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 172, doi. 10.1046/j.1468-1293.2000.00024-43.x

By:

Hayman, A;
Moss, T;
Arnold, C;
Naylor-Adamson, l;
Hawkswell, J;
Allen, K;
Radford, J;
Nguyen-Van-Tam, J;
Balfe, P

Publication type:

Article

023 Undiagnosed symptomatic acute HIV infections: a 12-month retrospective analysis of cases in South London.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-45.x

By:

Melzer, M;
Brown, M;
O'Shea, S;
Mullen, J;
Parry, J;
Chrystie, I;
Banatvala, J

Publication type:

Article

024 Mortality in the HAART era.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-47.x

By:

Sullivan, Ak;
Mazhude, C;
Nelson, M;
Fisher, M;
Chard, S;
Gazzard, B

Publication type:

Article

O3 Which are the most clinically useful questions in assessing adherence (AD)? A prospective comparative study.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 166, doi. 10.1046/j.1468-1293.2000.00024-5.x

By:

Walsh, Jc;
Gazzard, B

Publication type:

Article

O4 A novel point mutation assay for the detection of resistance to non-nucleoside reverse transcriptase inhibitors.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-7.x

By:

Frater, A. J.;
Braganza, R.;
Clarke, J. R.;
Weber, J. N.;
McClure, M. O.

Publication type:

Article

O5 Genotypic drug-resistance testing in early HIV infection.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-9.x

By:

Dean, Gl;
Cane, P;
Ratcliffe, D;
Workman, J;
Pillay, D;
Williams, Di;
Churchill, Dr;
Fisher, M

Publication type:

Article

O6 Genotypic resistance mutations and virological response to combination therapy in a clinical cohort.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-11.x

By:

Quigg, M;
Harris, D;
Precious, H;
Clutterbuck, D;
Nicoll, S;
Burns, S;
McMillan, A;
Leen, C;
Brown, Aj Leigh

Publication type:

Article

O7 Structural solution of the HIV-1 packaging signal and use of RNA transcripts containing the signal as potential antiviral molecules.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 167, doi. 10.1046/j.1468-1293.2000.00024-13.x

By:

Lever, Aml;
Dorman, N;
Chadwick, D;
Hassard, S;
Zeffman, A;
Varani, G

Publication type:

Article

O8 HIV post-exposure prophylaxis (PEP): a retrospective review.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 168, doi. 10.1046/j.1468-1293.2000.00024-15.x

By:

Benn, P;
Mercey, D;
Williams, Ig

Publication type:

Article

09 One-year UK experience of nelfinavir in paediatric HIV-1.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 168, doi. 10.1046/j.1468-1293.2000.00024-17.x

By:

Mitchla, Z.;
Sharland, M.;
Delmas, N.;
Gibb, D.;
Tudor-Williams, G.;
Ball, C.;
Dumont, G.;
Klein, N.

Publication type:

Article

P1 Assessing the role of treatment adherence in a clinical setting.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 173, doi. 10.1046/j.1468-1293.2000.00024-49.x

By:

Jones, T;
Pillay, D;
Sabin, C;
Back, D;
Wilkins, E;
Lloyd, J;
Verbiest, W

Publication type:

Article

P10 The relationships between ethnicity, gender, risk factor and viral load (VL) in HIV-1 antiretroviral naive patients.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-67.x

By:

Saul, J;
Kulasegaram, R;
Sabin, C;
Erwin, J;
Peters, B

Publication type:

Article

P11 Access to HIV medical services by HIV-positive black Africans in London.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-69.x

By:

Erwin, J;
Gray, K;
Saul, J;
Peters, B

Publication type:

Article

P12 Uptake of antiretroviral therapy by African patients in a District General Hospital.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 176, doi. 10.1046/j.1468-1293.2000.00024-71.x

By:

Rodgers, M;
Newell, A

Publication type:

Article

P13 Assessing health-related quality-of-life in individuals with HIV/AIDS in the era of HAART.

Published in:

HIV Medicine, 2000, v. 1, n. 3, p. 177, doi. 10.1046/j.1468-1293.2000.00024-73.x

By:

Miners, A;
Sabin, C;
Youle, M;
Mocroft, A;
Dykhoff, A;
Drinkwater, A;
Johnson, M;
Consortium, The Hiv Health Economics

Publication type:

Article